#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	2202	16S	1529	1529	100.0	16S.l15.c30.ctg.1	1938	213.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1368	1368	C	218	C,A	139,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4262	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	217.2	0	.	n	.	0	T695C	SNP	695	695	T	1020	1020	C	224	C	139	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4262	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	217.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1662	1662	A	246	A	160	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4262	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	217.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2296	2296	C	208	C	133	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4262	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	217.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2922	2922	T	249	T,C	113,48	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4262	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3663	217.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2370	2370	A	241	A	151	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	820	folP	852	852	100.0	folP.l6.c4.ctg.1	1627	96.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1076	1078	AGC	150;152;149	A;G;C	96;98;96	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1136	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3328	64.1	1	SNP	p	S91F	0	.	.	271	273	TCC	545	547	TCC	85;85;85	T;C,A;C	51;51,1;52	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1136	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3328	64.1	1	SNP	p	D95G	0	.	.	283	285	GAC	557	559	GAC	90;90;90	G;A;C	56;55;56	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1136	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3328	64.1	1	SNP	p	D95N	0	.	.	283	285	GAC	557	559	GAC	90;90;90	G;A;C	56;55;56	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	310	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1394	45.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	392	394	ACC	94;94;92	A;C;C,G	55;56;54,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	310	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1394	45.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	407	409	CAC	90;91;91	C;A,C;C	55;52,1;55	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	310	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1394	45.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	590	592	CAC	81;81;81	C,T,A;A,C;C	55,1,1;54,2;56	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	310	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1394	45.3	1	SNP	p	G45D	0	.	.	133	135	GGC	410	412	GGC	91;91;91	G;G;C	56;54;54	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	308	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	873	65.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1188	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	74.5	1	SNP	p	D86N	0	.	.	256	258	GAC	591	593	GAC	93;92;93	G;A;C	56;53;59	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1188	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	74.5	1	SNP	p	S87W	0	.	.	259	261	AGT	594	596	AGT	90;91;92	A;G;T	55;53;56	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1188	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	74.5	1	SNP	p	S87R	0	.	.	259	261	AGT	594	596	AGT	90;91;92	A;G;T	55;53;56	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1188	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	74.5	1	SNP	p	S87I	0	.	.	259	261	AGT	594	596	AGT	90;91;92	A;G;T	55;53;56	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1188	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	74.5	1	SNP	p	S88P	0	.	.	262	264	TCC	597	599	TCC	92;93;92	T;C;C	53;56;56	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1364	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2649	97.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	95;96;98	G;G;C	62;60;60	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1184	1186	GCA	105;105;105	G;C;A	69;70;69	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1187	1189	ATC	107;106;106	A;T;C	71;71;71	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1199	1201	GTG	102;102;102	G;T,C;G	66;64,1;66	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1199	1201	GTG	102;102;102	G;T,C;G	66;64,1;66	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1703	1705	ACC	92;94;94	A;C;C	56;58;60	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1757	1759	GCG	82;82;82	G;C;G	56;55;53	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1757	1759	GCG	82;82;82	G;C;G	56;55;53	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1880	1882	GGC	94;97;94	G;G;C,G	61;63;60,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1889	1891	GGC	77;77;78	G;G;C	49;46;48	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1098	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2218	90.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1907	1909	CCG	76;74;74	C,G;C;G,C	49,1;46;43,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1134	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	2823	73.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	456	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1890	47.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	686	686	C	47	C	29	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	537	539	GGA	70;70;72	G;G;A,T	44;44;43,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	798	800	CTT	38;39;39	C,G;T;T,G	23,1;25;24,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	0	.	p	.	0	R143G	NONSYN	427	429	AGA	822	824	GGA	40;40;40	G;G;A	26;26;27	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	0	.	p	.	0	D171G	NONSYN	511	513	GAT	906	908	GGT	43;43;44	G;G;T,C	30;30;28,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	0	.	p	.	0	G189S	NONSYN	565	567	GGC	960	962	AGC	38;38;39	A;G;C,A	23;23;23,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1026	1026	T	41	T	26	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	1	SNP	p	G120K	0	.	.	358	360	GGT	753	755	GGT	39;41;40	G,A;G,A;T,G	23,1;24,1;24,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	1	SNP	p	A121D	0	.	.	361	363	GCC	756	758	GCC	41;41;41	G,A;C,A;C	25,1;25,1;27	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	406	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1691	48.5	1	SNP	p	A121N	0	.	.	361	363	GCC	756	758	GCC	41;41;41	G,A;C,A;C	25,1;25,1;27	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	283	1142	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4723	44.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2023	2025	AAT	59;57;56	A;A;T	40;40;39	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	78	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	919	16.1	1	SNP	p	V57M	1	.	.	169	171	ATG	573	575	ATG	22;22;22	A;T;G	13;14;14	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
